Submit Your Feeds

Business News • PR NewsWire • Swiss Pharmacan's Supplement Authorized for Immediate Clinical Study to Confirm Effectiveness Against Long-COVID

Swiss Pharmacan's Supplement Authorized for Immediate Clinical Study to Confirm Effectiveness Against Long-COVID
Swiss Pharmacan's Supplement Authorized for Immediate Clinical Study to Confirm Effectiveness Against Long-COVID

FRAUENFELD, Switzerland, Dec. 21, 2021 /PRNewswire/ -- "The use of ArtemiC Support has shown clear improvement of [long-COVID] symptoms after just a few days," states research collaborator Dr. Francisco Mera Cordero from the Catalan Health Authority DAP Costa de Ponent. COVID-19 is mainly...

View More : https://www.prnewswire.com:443/news-releases/swiss-pharmacans-supplement-authorized-for-immediate-clinical-study-to-conf...
Releted News by prnewswire
Chairman's Letter 2021
Multichain (previously Anyswap) raises a $60M financing round led by Binance Labs
Swiss Pharmacan's Supplement Authorized for Immediate Clinical Study to Confirm Effectiveness Against Long-COVID
World Intelligent Vehicle Conference 2021 Helps Shape the Future of the Vehicle Industry
Skanska builds pharmaceutical manufacturing facility in Woburn, Massachusetts, USA, for USD 125M, about SEK 1.1 billion
Home Sitemap Contact Us
© businessNewsNewsNews.com